Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 472 participants.

Also called NCT05910125

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 472 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05910125
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT05910125. Randomized; single masking; primary purpose treatment. Start 2023-07 (anticipated); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
Acronym
AGREE
Intervention (Drug)
Aspirin
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Alteplase
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (class: other)

Record details

Record id
cardio:ct-nct05910125
Content hash
6c56fd7631e3d9d87bed8d1a757c77aac02f1de8c4b9b8bcee234282d421ce63